Mangoceuticals, Common Stock Stock Analysis
MGRX Stock | 2.53 0.04 1.61% |
Mangoceuticals, Common Stock is fairly valued with Real Value of 2.48 and Hype Value of 2.53. The main objective of Mangoceuticals, Common stock analysis is to determine its intrinsic value, which is an estimate of what Mangoceuticals, Common Stock is worth, separate from its market price. There are two main types of Mangoceuticals, Common's stock analysis: fundamental analysis and technical analysis.
The Mangoceuticals, Common stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Mangoceuticals, Common is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Mangoceuticals, Stock trading window is adjusted to America/New York timezone.
Mangoceuticals, |
Mangoceuticals, Stock Analysis Notes
About 37.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mangoceuticals, Common recorded a loss per share of 5.7. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 16th of October 2024. To find out more about Mangoceuticals, Common Stock contact Jacob Cohen at (214) 242-9619 or learn more at https://www.mangoceuticals.com.Mangoceuticals, Common Investment Alerts
Mangoceuticals, Common generated a negative expected return over the last 90 days | |
Mangoceuticals, Common has high historical volatility and very poor performance | |
Mangoceuticals, Common has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 731.49 K. Net Loss for the year was (9.21 M) with profit before overhead, payroll, taxes, and interest of 4.85 K. | |
Mangoceuticals, Common generates negative cash flow from operations | |
About 37.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from MacroaxisInsider: Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 |
Mangoceuticals, Common Upcoming and Recent Events
Earnings reports are used by Mangoceuticals, Common to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
26th of January 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Mangoceuticals, Common Environmental, Social, and Governance (ESG) Scores
Mangoceuticals, Common's ESG score is a quantitative measure that evaluates Mangoceuticals, Common's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Mangoceuticals, Common's operations that may have significant financial implications and affect Mangoceuticals, Common's stock price as well as guide investors towards more socially responsible investments.
Mangoceuticals, Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.29 M.Mangoceuticals, Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (8.77) | (8.33) | |
Return On Capital Employed | (10.98) | (10.43) | |
Return On Assets | (8.77) | (8.33) | |
Return On Equity | (11.89) | (11.30) |
Management Efficiency
Mangoceuticals, Common has return on total asset (ROA) of (0.5751) % which means that it has lost $0.5751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0844) %, meaning that it created substantial loss on money invested by shareholders. Mangoceuticals, Common's management efficiency ratios could be used to measure how well Mangoceuticals, Common manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -8.33 in 2024. Return On Capital Employed is likely to rise to -10.43 in 2024. At this time, Mangoceuticals, Common's Net Tangible Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 3.57 in 2024, whereas Total Assets are likely to drop slightly above 761.4 K in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.54 | 0.57 | |
Tangible Book Value Per Share | 0.54 | 0.57 | |
Enterprise Value Over EBITDA | (0.58) | (0.55) | |
Price Book Value Ratio | 7.65 | 8.03 | |
Enterprise Value Multiple | (0.58) | (0.55) | |
Price Fair Value | 7.65 | 8.03 | |
Enterprise Value | 4.8 M | 4.3 M |
The strategic initiatives led by Mangoceuticals, Common's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin (13.05) | Return On Assets (0.58) | Return On Equity (1.08) |
Technical Drivers
As of the 29th of November, Mangoceuticals, Common secures the Mean Deviation of 4.36, standard deviation of 6.16, and Risk Adjusted Performance of (0.05). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mangoceuticals, Common, as well as the relationship between them.Mangoceuticals, Common Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Mangoceuticals, Common middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Mangoceuticals, Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Mangoceuticals, Common Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mangoceuticals, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mangoceuticals, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mangoceuticals, Common insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mangoceuticals, Common Predictive Daily Indicators
Mangoceuticals, Common intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mangoceuticals, Common stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Mangoceuticals, Common Corporate Filings
10Q | 14th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 25th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 22nd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 21st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 11th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 3rd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Mangoceuticals, Common Forecast Models
Mangoceuticals, Common's time-series forecasting models are one of many Mangoceuticals, Common's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mangoceuticals, Common's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Mangoceuticals, Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Mangoceuticals, Common prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mangoceuticals, shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mangoceuticals, Common. By using and applying Mangoceuticals, Stock analysis, traders can create a robust methodology for identifying Mangoceuticals, entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (12.59) | (13.22) | |
Operating Profit Margin | (12.60) | (13.23) | |
Net Loss | (12.59) | (13.22) | |
Gross Profit Margin | 0.59 | 0.46 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Mangoceuticals, Common to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.